Breaking News

Cellares Completes New cGMP Cell Shuttle in Bridgewater, NJ

Marks a key step toward the IDMO Smart Factory’s full operational capacity.

Author Image

By: Charlie Sternberg

Associate Editor

Cellares, an Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and commercial-scale cell therapy manufacturing, announced today the successful completion of its first cGMP Cell Shuttle at itsIDMO Smart Factory in Bridgewater, New Jersey. This significant milestone marks a key step towards the facility’s full operational capacity, which will enable the production of up to 40,000 standard CAR-T cell therapy doses per year.   The Bridgewater facility, a state-of-t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters